Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma

Published:2003-03-20 Issue:5 Volume:14 Page:483-494
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Märten Angela¹,Renoth Sabine,Heinicke Thomas,Albers Peter,Pauli Andreas,Mey Ulrich,Caspari Reiner,Flieger Dimitri,Hanfland Peter,von Ruecker Alexander,Eis-Hübinger Anna M.,Müller Stefan,Schwaner Ingo,Lohmann Uwe,Heylmann Guido,Sauerbruch Tilman,Schmidt-Wolf Ingo G.H.

Affiliation:

1. Department of Internal Medicine I, University of Bonn, 53105 Bonn, Germany

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303403321467243

Reference25 articles.

1. Dendritic cells and the control of immunity

2. Europium-labelled target cells in an assay of natural killer cell activity

3. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.